Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 322

    1.

    Caveolinopathies: from the biology of caveolin-3 to human diseases.

    Gazzerro E, Sotgia F, Bruno C, Lisanti MP, Minetti C.

    Eur J Hum Genet. 2009 Dec;17(12):1692. No abstract available. PMID: 19924128 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Genetic ablation of caveolin-1 increases neural stem cell proliferation in the subventricular zone (SVZ) of the adult mouse brain.

    Jasmin JF, Yang M, Iacovitti L, Lisanti MP.

    Cell Cycle. 2009 Dec;8(23):3978-83. Epub 2009 Dec 28.PMID: 19923909 [PubMed - in process]Related articles

    3.

    The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma.

    Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP.

    Cell Cycle. 2009 Dec;8(23):3984-4001. Epub 2009 Dec 5.PMID: 19923890 [PubMed - in process]Related articles

    4.

    Post-obstructive regeneration of the kidney is derailed, when surge in renal stem cells during the course of unilateral ureteral obstruction is halted.

    Park HC, Yasuda K, Ratliff B, Stoessel A, Sharkovska Y, Yamamoto I, Jasmin JF, Bachmann S, Lisanti MP, Chander PN, Goligorsky MS.

    Am J Physiol Renal Physiol. 2009 Nov 11. [Epub ahead of print]PMID: 19906947 [PubMed - as supplied by publisher]Related articles

    5.

    Foxp3-expressing T regulatory cells and mast cells in acute graft-versus-host disease of the skin.

    Wu KN, Emmons RV, Lisanti MP, Farber JL, Witkiewicz AK.

    Cell Cycle. 2009 Nov 1;8(21):3593-7. Epub 2009 Nov 4.PMID: 19838066 [PubMed - in process]Related articles

    6.

    Chagas disease, adipose tissue and the metabolic syndrome.

    Nagajyothi F, Desruisseaux MS, Weiss LM, Chua S, Albanese C, Machado FS, Esper L, Lisanti MP, Teixeira MM, Scherer PE, Tanowitz HB.

    Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:219-25.PMID: 19753477 [PubMed - in process]Related articlesFree article

    7.

    Caveolinopathies: from the biology of caveolin-3 to human diseases.

    Gazzerro E, Sotgia F, Bruno C, Lisanti MP, Minetti C.

    Eur J Hum Genet. 2009 Jul 8. [Epub ahead of print]PMID: 19584897 [PubMed - as supplied by publisher]Related articles

    8.

    PPARgamma activation induces autophagy in breast cancer cells.

    Zhou J, Zhang W, Liang B, Casimiro MC, Whitaker-Menezes D, Wang M, Lisanti MP, Lanza-Jacoby S, Pestell RG, Wang C.

    Int J Biochem Cell Biol. 2009 Nov;41(11):2334-42. Epub 2009 Jun 26.PMID: 19563910 [PubMed - in process]Related articles

    9.

    An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation.

    Di Vizio D, Morello M, Sotgia F, Pestell RG, Freeman MR, Lisanti MP.

    Cell Cycle. 2009 Aug;8(15):2420-4. Epub 2009 Aug 27.PMID: 19556867 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Caveolin-1 tumor-promoting role in human melanoma.

    Felicetti F, Parolini I, Bottero L, Fecchi K, Errico MC, Raggi C, Biffoni M, Spadaro F, Lisanti MP, Sargiacomo M, Carè A.

    Int J Cancer. 2009 Oct 1;125(7):1514-22.PMID: 19521982 [PubMed - indexed for MEDLINE]Related articles

    11.

    Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer.

    Witkiewicz AK, Dasgupta A, Nguyen KH, Liu C, Kovatich AJ, Schwartz GF, Pestell RG, Sotgia F, Rui H, Lisanti MP.

    Cancer Biol Ther. 2009 Jun;8(11):1071-9. Epub 2009 Jun 29.PMID: 19502809 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Altered expression of DACH1 and cyclin D1 in endometrial cancer.

    Nan F, Lü Q, Zhou J, Cheng L, Popov VM, Wei S, Kong B, Pestell RG, Lisanti MP, Jiang J, Wang C.

    Cancer Biol Ther. 2009 Aug;8(16):1534-9. Epub 2009 Aug 8.PMID: 19502783 [PubMed - in process]Related articles

    13.

    Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy.

    Witkiewicz AK, Casimiro MC, Dasgupta A, Mercier I, Wang C, Bonuccelli G, Jasmin JF, Frank PG, Pestell RG, Kleer CG, Sotgia F, Lisanti MP.

    Cell Cycle. 2009 Jun 1;8(11):1654-8.PMID: 19448435 [PubMed - indexed for MEDLINE]Related articles

    14.

    Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival.

    Brody JR, Costantino CL, Berger AC, Sato T, Lisanti MP, Yeo CJ, Emmons RV, Witkiewicz AK.

    Cell Cycle. 2009 Jun 15;8(12):1930-4. Epub 2009 Jun 15.PMID: 19448397 [PubMed - indexed for MEDLINE]Related articles

    15.

    A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1.

    Rodriguez OC, Lai EW, Vissapragada S, Cromelin C, Avetian M, Salinas P, Ramos H, Kallakury B, Casimiro M, Lisanti MP, Tanowitz HB, Pacak K, Glazer RI, Avantaggiati M, Albanese C.

    Am J Pathol. 2009 Jun;174(6):2051-60. Epub 2009 May 14.PMID: 19443706 [PubMed - indexed for MEDLINE]Related articles

    16.

    An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers.

    Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell RG, Sabel M, Kleer CG, Brody JR, Lisanti MP.

    Am J Pathol. 2009 Jun;174(6):2023-34. Epub 2009 May 1.PMID: 19411448 [PubMed - indexed for MEDLINE]Related articles

    17.

    Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature.

    Bonuccelli G, Casimiro MC, Sotgia F, Wang C, Liu M, Katiyar S, Zhou J, Dew E, Capozza F, Daumer KM, Minetti C, Milliman JN, Alpy F, Rio MC, Tomasetto C, Mercier I, Flomenberg N, Frank PG, Pestell RG, Lisanti MP.

    Am J Pathol. 2009 May;174(5):1650-62.PMID: 19395651 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Using Caveolin-1 epithelial immunostaining patterns to stratify human breast cancer patients and predict the Caveolin-1 (P132L) mutation.

    Mercier I, Bryant KG, Sotgia F, Bonuccelli G, Witkiewicz AK, Dasgupta A, Jasmin JF, Pestell RG, Lisanti MP.

    Cell Cycle. 2009 May 1;8(9):1396-401. Epub 2009 May 26.PMID: 19342880 [PubMed - indexed for MEDLINE]Related articles

    19.

    Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.

    Mercier I, Casimiro MC, Zhou J, Wang C, Plymire C, Bryant KG, Daumer KM, Sotgia F, Bonuccelli G, Witkiewicz AK, Lin J, Tran TH, Milliman J, Frank PG, Jasmin JF, Rui H, Pestell RG, Lisanti MP.

    Am J Pathol. 2009 Apr;174(4):1172-90.PMID: 19342371 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders.

    Mercier I, Jasmin JF, Pavlides S, Minetti C, Flomenberg N, Pestell RG, Frank PG, Sotgia F, Lisanti MP.

    Lab Invest. 2009 Jun;89(6):614-23. Epub 2009 Mar 30. Review.PMID: 19333235 [PubMed - indexed for MEDLINE]Related articles

    21.

    Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.

    Sotgia F, Del Galdo F, Casimiro MC, Bonuccelli G, Mercier I, Whitaker-Menezes D, Daumer KM, Zhou J, Wang C, Katiyar S, Xu H, Bosco E, Quong AA, Aronow B, Witkiewicz AK, Minetti C, Frank PG, Jimenez SA, Knudsen ES, Pestell RG, Lisanti MP.

    Am J Pathol. 2009 Mar;174(3):746-61.PMID: 19234134 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype.

    Nagajyothi F, Desruisseaux MS, Thiruvur N, Weiss LM, Braunstein VL, Albanese C, Teixeira MM, de Almeida CJ, Lisanti MP, Scherer PE, Tanowitz HB.

    Obesity (Silver Spring). 2008 Sep;16(9):1992-7.PMID: 19186325 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Caveolin-1 expression determines the route of neutrophil extravasation through skin microvasculature.

    Marmon S, Hinchey J, Oh P, Cammer M, de Almeida CJ, Gunther L, Raine CS, Lisanti MP.

    Am J Pathol. 2009 Feb;174(2):684-92.PMID: 19164603 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation.

    Sotgia F, Casimiro MC, Bonuccelli G, Liu M, Whitaker-Menezes D, Er O, Daumer KM, Mercier I, Witkiewicz AK, Minetti C, Capozza F, Gormley M, Quong AA, Rui H, Frank PG, Milliman JN, Knudsen ES, Zhou J, Wang C, Pestell RG, Lisanti MP.

    Am J Pathol. 2009 Feb;174(2):613-29.PMID: 19164602 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Switch to oral hypoglycemic agent therapy from insulin injection in patients with type 2 diabetes.

    Okamoto T, Okamoto L, Lisanti MP, Akishita M.

    Geriatr Gerontol Int. 2008 Dec;8(4):218-26.PMID: 19149832 [PubMed - indexed for MEDLINE]Related articles

    26.

    Transcellular migration of neutrophils is a quantitatively significant pathway across dermal microvascular endothelial cells.

    Marmon S, Cammer M, Raine CS, Lisanti MP.

    Exp Dermatol. 2009 Jan;18(1):88-90. Epub 2008 Nov 19.PMID: 19040450 [PubMed - indexed for MEDLINE]Related articles

    27.

    Chemokine transport and leukocyte extravasation through dermal microvasculature in the absence of caveolae.

    Marmon S, Hinchey J, Raine CS, Lisanti MP.

    J Dermatol Sci. 2009 Mar;53(3):225-8. Epub 2008 Nov 18. No abstract available. PMID: 19019633 [PubMed - indexed for MEDLINE]Related articles

    28.

    Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis.

    Del Galdo F, Lisanti MP, Jimenez SA.

    Curr Opin Rheumatol. 2008 Nov;20(6):713-9. Review.PMID: 18949888 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcome.

    Witkiewicz AK, Nguyen KH, Dasgupta A, Kennedy EP, Yeo CJ, Lisanti MP, Brody JR.

    Cell Cycle. 2008 Oct;7(19):3021-5. Epub 2008 Oct 23.PMID: 18802406 [PubMed - indexed for MEDLINE]Related articles

    30.

    Decreased expression of caveolin 1 in patients with systemic sclerosis: Crucial role in the pathogenesis of tissue fibrosis.

    Galdo FD, Sotgia F, de Almeida CJ, Jasmin JF, Musick M, Lisanti MP, Jiménez SA.

    Arthritis Rheum. 2008 Sep;58(9):2854-65.PMID: 18759267 [PubMed - in process]Related articlesFree article

    31.

    Hearts lacking caveolin-1 develop hypertrophy with normal cardiac substrate metabolism.

    Augustus AS, Buchanan J, Gutman E, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP.

    Cell Cycle. 2008 Aug 15;7(16):2509-18. Epub 2008 Aug 26.PMID: 18719368 [PubMed - indexed for MEDLINE]Related articles

    32.

    ICAM-1: role in inflammation and in the regulation of vascular permeability.

    Frank PG, Lisanti MP.

    Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H926-H927. Epub 2008 Aug 8. No abstract available. PMID: 18689494 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Caveolae and transcytosis in endothelial cells: role in atherosclerosis.

    Frank PG, Pavlides S, Lisanti MP.

    Cell Tissue Res. 2009 Jan;335(1):41-7. Epub 2008 Aug 8. Review.PMID: 18688651 [PubMed - indexed for MEDLINE]Related articles

    34.

    Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathies.

    Assereto S, Mastrototaro M, Stringara S, Gazzerro E, Broda P, Nicchia GP, Svelto M, Bruno C, Nigro V, Lisanti MP, Frigeri A, Minetti C.

    Cell Cycle. 2008 Jul 15;7(14):2199-207. Epub 2008 May 12.PMID: 18641458 [PubMed - indexed for MEDLINE]Related articles

    35.

    Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase.

    Di Vizio D, Adam RM, Kim J, Kim R, Sotgia F, Williams T, Demichelis F, Solomon KR, Loda M, Rubin MA, Lisanti MP, Freeman MR.

    Cell Cycle. 2008 Jul 15;7(14):2257-67. Epub 2008 May 12.PMID: 18635971 [PubMed - indexed for MEDLINE]Related articles

    36.

    Selective cytotoxicity of synthesized procyanidin 3-O-galloylepicatechin-4b, 8-3-O-galloylcatechin to human cancer cells.

    Kim M, Wu X, Song I, Fu M, Chang SH, Lisanti MP, Pestell R.

    Cell Cycle. 2008 Jun 1;7(11):1648-57. Epub 2008 Mar 21.PMID: 18560275 [PubMed - indexed for MEDLINE]Related articles

    37.

    Genes contributing to prion pathogenesis.

    Tamgüney G, Giles K, Glidden DV, Lessard P, Wille H, Tremblay P, Groth DF, Yehiely F, Korth C, Moore RC, Tatzelt J, Rubinstein E, Boucheix C, Yang X, Stanley P, Lisanti MP, Dwek RA, Rudd PM, Moskovitz J, Epstein CJ, Cruz TD, Kuziel WA, Maeda N, Sap J, Ashe KH, Carlson GA, Tesseur I, Wyss-Coray T, Mucke L, Weisgraber KH, Mahley RW, Cohen FE, Prusiner SB.

    J Gen Virol. 2008 Jul;89(Pt 7):1777-88.PMID: 18559949 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts.

    Augustus AS, Buchanan J, Addya S, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP.

    Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H657-66. Epub 2008 Jun 13.PMID: 18552160 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Role of caveolin-1 in the regulation of lipoprotein metabolism.

    Frank PG, Pavlides S, Cheung MW, Daumer K, Lisanti MP.

    Am J Physiol Cell Physiol. 2008 Jul;295(1):C242-8. Epub 2008 May 28.PMID: 18508910 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Stat3 promotes metastatic progression of prostate cancer.

    Abdulghani J, Gu L, Dagvadorj A, Lutz J, Leiby B, Bonuccelli G, Lisanti MP, Zellweger T, Alanen K, Mirtti T, Visakorpi T, Bubendorf L, Nevalainen MT.

    Am J Pathol. 2008 Jun;172(6):1717-28. Epub 2008 May 15.PMID: 18483213 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    ARC (apoptosis repressor with caspase recruitment domain) is a novel marker of human colon cancer.

    Mercier I, Vuolo M, Jasmin JF, Medina CM, Williams M, Mariadason JM, Qian H, Xue X, Pestell RG, Lisanti MP, Kitsis RN.

    Cell Cycle. 2008 Jun 1;7(11):1640-7. Epub 2008 Mar 19.PMID: 18469522 [PubMed - indexed for MEDLINE]Related articles

    42.

    Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8.

    Wu K, Katiyar S, Li A, Liu M, Ju X, Popov VM, Jiao X, Lisanti MP, Casola A, Pestell RG.

    Proc Natl Acad Sci U S A. 2008 May 13;105(19):6924-9. Epub 2008 May 8.PMID: 18467491 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy.

    Mercier I, Casimiro MC, Wang C, Rosenberg AL, Quong J, Minkeu A, Allen KG, Danilo C, Sotgia F, Bonuccelli G, Jasmin JF, Xu H, Bosco E, Aronow B, Witkiewicz A, Pestell RG, Knudsen ES, Lisanti MP.

    Cancer Biol Ther. 2008 Aug;7(8):1212-25. Epub 2008 Aug 30.PMID: 18458534 [PubMed - indexed for MEDLINE]Related articles

    44.

    Biotinylation and analysis of membrane-bound and soluble proteins.

    Lisanti MP, Sargiacomo M.

    Curr Protoc Immunol. 2001 May;Chapter 8:Unit 8.16.PMID: 18432856 [PubMed - indexed for MEDLINE]Related articles

    45.

    Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection.

    Mukherjee S, Nagajyothi F, Mukhopadhyay A, Machado FS, Belbin TJ, Campos de Carvalho A, Guan F, Albanese C, Jelicks LA, Lisanti MP, Silva JS, Spray DC, Weiss LM, Tanowitz HB.

    Genomics. 2008 May;91(5):423-32. Epub 2008 Mar 17.PMID: 18343633 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro.

    Traverso M, Gazzerro E, Assereto S, Sotgia F, Biancheri R, Stringara S, Giberti L, Pedemonte M, Wang X, Scapolan S, Pasquini E, Donati MA, Zara F, Lisanti MP, Bruno C, Minetti C.

    Lab Invest. 2008 Mar;88(3):275-83. Epub 2008 Feb 4.PMID: 18253147 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Inhibition of cyclin D1 gene transcription by Brg-1.

    Rao M, Casimiro MC, Lisanti MP, D'Amico M, Wang C, Shirley LA, Leader JE, Liu M, Stallcup M, Engel DA, Murphy DJ, Pestell RG.

    Cell Cycle. 2008 Mar 1;7(5):647-55. Epub 2007 Dec 12.PMID: 18239461 [PubMed - indexed for MEDLINE]Related articles

    48.

    Regulation of host cell cyclin D1 by Trypanosoma cruzi in myoblasts.

    Bouzahzah B, Yurchenko V, Nagajyothi F, Hulit J, Sadofsky M, Braunstein VL, Mukherjee S, Weiss H, Machado FS, Pestell RG, Lisanti MP, Tanowitz HB, Albanese C.

    Cell Cycle. 2008 Feb 15;7(4):500-3. Epub 2007 Nov 18.PMID: 18239452 [PubMed - indexed for MEDLINE]Related articles

    49.

    Analysis of the association of proteins with membranes.

    Okamoto T, Schwab RB, Scherer PE, Lisanti MP.

    Curr Protoc Cell Biol. 2001 May;Chapter 5:Unit 5.4.PMID: 18228372 [PubMed - indexed for MEDLINE]Related articles

    50.

    Disruption of c-Jun reduces cellular migration and invasion through inhibition of c-Src and hyperactivation of ROCK II kinase.

    Jiao X, Katiyar S, Liu M, Mueller SC, Lisanti MP, Li A, Pestell TG, Wu K, Ju X, Li Z, Wagner EF, Takeya T, Wang C, Pestell RG.

    Mol Biol Cell. 2008 Apr;19(4):1378-90. Epub 2008 Jan 23.PMID: 18216279 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...